Frontotemporal dementia trials in Sweden

2 of 4 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Not yet taking people in Sweden
  A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)

  Where

  Lund

  Age

  30 years to 75 years

  People

  18 worldwide

  Run by

  AviadoBio Ltd

  See details and how to joinNCT06064890 · EU 2023-509444-10-00
• Phase 2Taking people
  The Swedish BioFINDER 2 Study

  Where

  Malmö

  Age

  20 years to 100 years

  People

  2,950

  Run by

  Skane University Hospital

  See details and how to joinNCT03174938 · EU 2024-511842-38-00